Gabelli & Co Investment Advisers’s GenMark Diagnostics, Inc GNMK Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-208,794	Closed	-$4.99M	–	549
2021 Q1	$4.99M	Buy	+208,794	New	+$3.88M	0.62%	42

Gabelli & Co Investment Advisers's GNMK Position: Q2 2021 in Review

Gabelli & Co Investment Advisers sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 208,794 shares — an estimated $4.99M sold.

Gabelli & Co Investment Advisers first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $4.99M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Gabelli & Co Investment Advisers reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 208,794 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $4.99M.
Gabelli & Co Investment Advisers first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Gabelli & Co Investment Advisers's GenMark Diagnostics, Inc position peaked at $4.99M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.